Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.
about
Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@en
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@nl
type
label
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@en
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@nl
prefLabel
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@en
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@nl
P2093
P2860
P356
P1433
P1476
Wild-type KRAS is a novel ther ...... resistance to BRAF inhibition.
@en
P2093
C Hellerbrand
P Dietrich
P2860
P2888
P356
10.1038/ONC.2017.391
P407
P577
2017-10-23T00:00:00Z